1 Watson, J., Whiting, P. F. & Brush, J. E. Interpreting a covid-19 test result. Bmj 369, m1808, doi:10.1136/bmj.m1808 PMID - 32398230 (2020).
2 Vandenberg, O., Martiny, D., Rochas, O., Belkum, A. v. & Kozlakidis, Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol 19, 171-183, doi:10.1038/s41579-020-00461-z PMID - 33057203 (2021).
3 Food, U. & Administration, D. In vitro diagnostics EUAs—antigen diagnostic tests for SARS-CoV-2. FDA, Silver Spring, MD. https://www. fda. gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2.[Google Scholar] (2021).
4 Qiu, G. et al. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection. ACS Nano 14, acsnano.0c02439, doi:10.1021/acsnano.0c02439 PMID - 32281785 (2020).
5 Macchia, E. et al. A handheld intelligent single-molecule binary bioelectronic system for fast and reliable immunometric point-of-care testing. Science Advances 8, eabo0881, doi:10.1126/sciadv.abo0881 PMID - 35857467 (2022).
6 Lee, J. H. et al. A rapid quantitative on-site coronavirus disease 19 serological test. Biosensors and Bioelectronics 191, 113406, doi:10.1016/j.bios.2021.113406 PMID - 34167074 (2021).
7 Fozouni, P. et al. Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy. Cell 184, 323-333.e329, doi:10.1016/j.cell.2020.12.001 PMID - 33306959 (2021).
8 Crozier, A., Rajan, S., Buchan, I. & McKee, M. Put to the test: use of rapid testing technologies for covid-19. Bmj 372, n208, doi:10.1136/bmj.n208 PMID - 33536228 (2021).
9 Chen, Y., Liu, F. & Lee, L. P. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Science Advances 8, eabn3481, doi:10.1126/sciadv.abn3481 PMID - 35613342 (2022).
10 Seo, G. et al. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor. ACS Nano 14, acsnano.0c02823, doi:10.1021/acsnano.0c02823 PMID - 32293168 (2020).
11 Ferreira, A. L., de Lima, L. F., Torres, M. T., de Araujo, W. R. & de la Fuente-Nunez, C. Low-Cost Optodiagnostic for Minute-Time Scale Detection of SARS-CoV-2. ACS Nano, doi:10.1021/acsnano.1c03236 (2021).
12 Mei, X. et al. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19. Nature Medicine 26, 1224-1228, doi:10.1038/s41591-020-0931-3 PMID - 32427924 (2020).
13 Cheong, J. et al. Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device. Nature Biomedical Engineering 4, 1159-1167, doi:10.1038/s41551-020-00654-0 PMID - 33273713 (2020).
14 Teymouri, M. et al. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathology - Research and Practice 221, 153443, doi:https://doi.org/10.1016/j.prp.2021.153443 (2021).
15 Shani-Narkiss, H., Gilday, O. D., Yayon, N. & Landau, I. D. Efficient and Practical Sample Pooling for High-Throughput PCR Diagnosis of COVID-19. medRxiv, 2020.2004.2006.20052159, doi:10.1101/2020.04.06.20052159 (2020).
16 Lai, C.-C., Wang, C.-Y., Ko, W.-C. & Hsueh, P.-R. In vitro diagnostics of coronavirus disease 2019: Technologies and application. Journal of Microbiology, Immunology and Infection 54, 164-174, doi:https://doi.org/10.1016/j.jmii.2020.05.016 (2021).
17 Pokharel, S. et al. Two-test algorithms for infectious disease diagnosis: Implications for COVID-19. PLOS Global Public Health 2, e0000293, doi:10.1371/journal.pgph.0000293 (2022).
18 Santiago, I. Trends and Innovations in Biosensors for COVID-19 Mass Testing. ChemBioChem 21, 2880-2889, doi:https://doi.org/10.1002/cbic.202000250 (2020).
19 Mina, M. J., Parker, R. & Larremore, D. B. Rethinking Covid-19 Test Sensitivity — A Strategy for Containment. New Engl J Med 383, e120, doi:10.1056/nejmp2025631 PMID - 32997903 (2020).
20 Cevik, M., Kuppalli, K., Kindrachuk, J. & Peiris, M. Virology, transmission, and pathogenesis of SARS-CoV-2. Bmj 371, m3862, doi:10.1136/bmj.m3862 PMID - 33097561 (2020).
21 Cevik, M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2, e13-e22, doi:10.1016/s2666-5247(20)30172-5 PMID - 33521734 (2021).
22 Singh, N. K. et al. Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer. Biosensors and Bioelectronics 180, 113111, doi:10.1016/j.bios.2021.113111 PMID - 33743492 (2021).
23 Fernandes, H. P., Cesar, C. L. & Barjas-Castro, M. d. L. Electrical properties of the red blood cell membrane and immunohematological investigation. Revista Brasileira De Hematologia E Hemoterapia 33, 297-301, doi:10.5581/1516-8484.20110080 PMID - 23049321 (2011).
24 Bloom, J. A. & Webb, W. W. Lipid diffusibility in the intact erythrocyte membrane. Biophys J 42, 295-305, doi:10.1016/s0006-3495(83)84397-5 PMID - 6603237 (1983).
25 Filippov, A., Orädd, G. & Lindblom, G. The Effect of Cholesterol on the Lateral Diffusion of Phospholipids in Oriented Bilayers. Biophys J 84, 3079-3086, doi:10.1016/s0006-3495(03)70033-2 PMID - 12719238 (2003).
26 Li, Y. et al. Water-ion permselectivity of narrow-diameter carbon nanotubes. Science Advances 6, eaba9966, doi:10.1126/sciadv.aba9966 PMID - 32938679 (2020).
27 Joo, B., Hur, J., Kim, G.-B., Yun, S. G. & Chung, A. J. Highly Efficient Transfection of Human Primary T Lymphocytes Using Droplet-Enabled Mechanoporation. ACS Nano 15, 12888-12898, doi:10.1021/acsnano.0c10473 PMID - 34142817 (2021).
28 Ding, X. et al. High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruption. Nature Biomedical Engineering 1, 0039, doi:10.1038/s41551-017-0039 (2017).
29 Nel, A. E. et al. Understanding biophysicochemical interactions at the nano–bio interface. Nature Materials 8, 543-557, doi:10.1038/nmat2442 PMID - 19525947 (2009).
30 Shang, W. et al. Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis. Vaccines (Basel) 10, doi:10.3390/vaccines10071049 (2022).
31 Wyllie, A. L. et al. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. New Engl J Medicine 383, NEJMc2016359, doi:10.1056/nejmc2016359 PMID - 32857487 (2020).
32 Ascoli, C. A. Could mutations of SARS-CoV-2 suppress diagnostic detection? Nature Biotechnology 39, 274-275, doi:10.1038/s41587-021-00845-3 (2021).
33 Quilty, B. J. et al. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study. Lancet Public Heal 6, e175-e183, doi:10.1016/s2468-2667(20)30308-x PMID - 33484644 (2021).
34 Organization, W. H. (World Health Organization, 2020).
35 Straightforward, inexpensive and sensitive. Nature Biomedical Engineering 6, 923-924, doi:10.1038/s41551-022-00935-w (2022).
36 Lee, S. et al. Sample-to-answer Platform for the Clinical Evaluation of COVID-19 using a Deep-learning-assisted Smartphone-based Assay. unpublished.
37 Land, K. J., Boeras, D. I., Chen, X.-S., Ramsay, A. R. & Peeling, R. W. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol 4, 46-54, doi:10.1038/s41564-018-0295-3 PMID - 30546093 (2019).